Dengue fever management
Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed
dengue AND management
Searching the Web
WHO dengue clinical management warning signs fluid management 2024
Reading File
Reading File
Reading File
Reading Web Page
https://www.cdc.gov/dengue/hcp/clinical-care/index.html
Dengue fever management
There is no specific antiviral treatment for dengue. Management is supportive, with early detection of plasma leakage, bleeding, shock, or organ involvement. CDC clinical care guidance uses clinical severity to decide home care, admission, or intensive care.
1. Uncomplicated dengue - usually outpatient care
Appropriate only if the patient can drink adequately, pass urine normally, has no warning signs or major comorbidity, and can return promptly for review.
- Oral fluids: water, oral rehydration solution, soups, electrolyte-containing fluids. Small frequent amounts if nauseated.
- Fever and pain: paracetamol/acetaminophen only.
- Avoid: aspirin, ibuprofen, naproxen, diclofenac, and other NSAIDs because they can increase bleeding risk. Avoid intramuscular injections where possible.
- Rest, monitor temperature, fluid intake, urine output, bleeding, and worsening abdominal symptoms.
- Clinical review and serial CBC/hematocrit are particularly important around days 3-7, often when fever begins to settle. A rising hematocrit with a rapidly falling platelet count may indicate plasma leakage.
Dengue’s critical phase commonly occurs around defervescence and lasts about 24-48 hours. - Red Book 2021, pp. 520-521
2. Warning signs - hospital assessment/admission
Seek urgent hospital care for any of the following:
- Severe or persistent abdominal pain/tenderness
- Persistent vomiting or inability to drink
- Mucosal bleeding, vomiting blood, black stools, heavy vaginal bleeding
- Lethargy, irritability, restlessness, fainting, or confusion
- Cold clammy extremities, reduced urine, dizziness/postural hypotension
- Breathing difficulty
- Fluid accumulation, such as ascites or pleural effusion
- Enlarged liver
- Rising hematocrit with rapidly decreasing platelets
Patients with warning signs need close monitoring and usually IV isotonic crystalloid fluids, such as normal saline or Ringer lactate, titrated to perfusion, urine output, hematocrit trend, and signs of fluid overload. Do not give large unmonitored fluid volumes, particularly after the leakage phase, because pulmonary edema/fluid overload can occur.
- Red Book 2021, p. 520
- CDC warning-sign guidance
3. Severe dengue - emergency/ICU care
Severe dengue includes any of:
- Shock from plasma leakage
- Respiratory distress from fluid accumulation
- Clinically significant bleeding
- Severe organ involvement, for example encephalopathy, myocarditis, acute liver injury, or acute kidney injury
Management requires emergency resuscitation, frequent reassessment, carefully titrated IV crystalloid boluses, monitoring of vital signs, urine output, hematocrit, electrolytes, acid-base status, and organ function. Colloids may be considered by experienced clinicians if shock does not respond to initial crystalloid resuscitation.
Give blood products for clinically significant bleeding or hemodynamic compromise, not simply for a low platelet number. Routine prophylactic platelet transfusion is generally not recommended. Steroids are not routinely recommended for dengue.
- Rosen’s Emergency Medicine, p. 2630
- Red Book 2021, p. 520
4. Who merits lower threshold for admission?
Admit or observe more readily if there is pregnancy, infancy, older age, obesity, diabetes, chronic kidney/liver/heart disease, anticoagulant or antiplatelet use, immunosuppression, social barriers to follow-up, or unreliable access to urgent care.
5. Discharge considerations
A patient should generally be clinically improving, afebrile for 24-48 hours without antipyretics, drinking adequately, producing urine normally, hemodynamically stable, without respiratory distress or bleeding, and have a stable or improving hematocrit/platelet trend.
Key point
A falling platelet count alone does not define severe dengue. The more concerning pattern is clinical deterioration or poor perfusion, together with hemoconcentration/rising hematocrit, especially as fever settles.
A 2025 systematic review also supports the current approach that dengue treatment remains primarily supportive, centered on careful fluid management and recognition of severe disease rather than antiviral therapy (PMID 41037858).
Fluid management protocol
Reading File
Finding Sources
Finding Sources
Searching PubMed
dengue AND fluid therapy
Searching the Web
dengue fluid management protocol adults children warning signs shock WHO PAHO crystalloid mL kg hour
Dengue fluid management protocol
Use only in a monitored clinical setting. In dengue, fluid treatment is guided by perfusion, urine output, hematocrit trend, and signs of overload, not platelet count alone. The period of plasma leakage is usually around defervescence and often lasts 24-48 hours.
Use isotonic crystalloids: 0.9% normal saline or Ringer lactate/Hartmann solution. Obtain a hematocrit before fluids when this will not delay treatment.
A. No warning signs
- Encourage oral fluids.
- IV fluids are usually unnecessary if oral intake and urine output are adequate.
- Review daily during febrile/critical-phase risk period, with CBC and hematocrit as indicated.
B. Dengue with warning signs, but no shock
Examples: persistent vomiting, abdominal pain/tenderness, mucosal bleed, clinical fluid accumulation, lethargy/restlessness, rising hematocrit, or poor oral intake.
| Step | IV isotonic crystalloid rate | Reassess |
|---|---|---|
| Initial | 10 mL/kg over 1 hour | Vitals, pulse pressure, capillary refill, urine output, hematocrit |
| If improving | 5-7 mL/kg/h for 2-4 h | Hourly while IV fluids run |
| Then if improving | 3-5 mL/kg/h for 2-4 h | Continue to reassess |
| Then if improving | 2-4 mL/kg/h, taper over the following 24-48 h | Switch to oral fluids as soon as tolerated |
Clinical improvement: warning signs resolving, stable BP and pulse pressure, warm peripheries, improving urine output, falling hematocrit in a stable patient, and ability to drink.
If no improvement but still hemodynamically stable: repeat 10 mL/kg over 1 hour, reassess after each bolus. If there is failure after repeated boluses or deterioration, manage as severe dengue/shock. The current PAHO dengue algorithm specifies this staged approach.
Older adults or patients with heart failure, kidney disease, chronic liver disease, pregnancy, or marked obesity: use smaller/more cautious initial fluid rates, often 5 mL/kg over 1 hour, with very frequent reassessment because fluid overload risk is higher.
C. Severe dengue with compensated or hypotensive shock
Signs include narrow pulse pressure, tachycardia, cool extremities, delayed capillary refill, oliguria, hypotension, altered sensorium, or metabolic acidosis.
- ABC stabilization, oxygen as needed, two IV lines, send CBC/hematocrit, group and cross-match, glucose, electrolytes, renal/liver tests, blood gas/lactate where available.
- Give isotonic crystalloid:
- Compensated shock: 5-10 mL/kg/h for 1 hour.
- Hypotensive shock: 20 mL/kg over 15-30 minutes.
- Reassess immediately: pulse pressure, BP, pulse quality, capillary refill, mental state, lungs, urine output, and hematocrit.
- If improving, reduce fluid stepwise, for example to 10 mL/kg/h, then 5-7 mL/kg/h, then taper based on response.
- If shock persists:
- Hematocrit high or rising: ongoing plasma leakage is likely. Give a further carefully monitored crystalloid bolus, commonly 10-20 mL/kg over 30-60 minutes. Consider colloid in refractory shock under senior/ICU supervision.
- Hematocrit falling with persistent shock: suspect major bleeding. Cross-match and give blood, typically fresh whole blood 10-20 mL/kg or packed red cells 5-10 mL/kg, according to local protocol and clinical assessment.
- Consider alternative/concurrent causes: occult bleeding, myocarditis/cardiogenic shock, acidosis, hypoglycemia, sepsis, or an incorrect diagnosis.
Monitoring targets
During active IV resuscitation, assess at least hourly:
- Pulse, blood pressure and pulse pressure
- Mental state and peripheral perfusion
- Respiratory rate, oxygen saturation, lung examination
- Strict input/output and urine output
- Hematocrit before treatment and serially as clinically indicated
- Signs of bleeding and fluid overload
Usual urine-output targets:
- Adults: at least 0.5 mL/kg/h
- Children: at least 1 mL/kg/h
Preventing fluid overload
As the recovery phase begins, leaked fluid is reabsorbed. Reduce or stop IV fluid early when perfusion is stable, oral intake is adequate, urine output rises, hematocrit falls appropriately, or there are signs of overload:
- Tachypnea or increasing oxygen requirement
- Crackles, pleural effusions, pulmonary edema
- Raised JVP, edema, enlarging liver
- New hypertension or worsening respiratory distress
Do not continue fluids merely because platelets are low. Routine prophylactic platelet transfusion is not indicated without significant bleeding or an invasive-procedure indication.
Rosen’s Emergency Medicine describes supportive care with IV fluid replacement and organ support for dengue hemorrhagic fever/shock, with blood products for clinically significant hemorrhage - p. 2630. The PAHO management guidance emphasizes hourly reassessment and stepwise de-escalation once perfusion improves.
This is a shared conversation. Sign in to Orris to start your own chat.